Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Cash flows from operating activities
Net loss	$ (4,640,904)	$ (1,524,321)
Adjustments for non-cash income and expenses:
Depreciation	29,166	95,369
Amortization	902,419	1,039,347
Stock based expense	3,261,676
Changes in operating assets and liabilities:
Increase in accounts receivables	(14,671)	(7,490)
Decrease/(increase) in inventories	50,862	(54,528)
Decrease in deposits, prepayments, and advances to suppliers	14,174	122,057
Decrease in operating lease right-of-use assets	26,975	17,590
(Decrease) /increase in accounts payable and accruals	(41,384)	118,749
Increase/(decrease) in deferred revenue	10,631	(49,986)
Decrease in operating lease liabilities	(28,186)	(18,518)
Increase/(decrease) in other payables	62,246	(8,387)
Increase in amounts due to shareholders	325,463	166,652
Net cash used in operations	(41,533)	(103,466)
Cash flows from investing activity
Purchase of property, plant and equipment		(107,725)
Net cash used in investing activity		(107,725)
Cash flows from financing activity
Payments of hire purchase	(2,346)	(1,972)
Net cash used in financing activity	(2,346)	(1,972)
Net decrease in cash and cash equivalents	(43,879)	(213,163)
Effect of exchange rate changes	40,626	(88,001)
Cash and cash equivalents at start of period	152,985	779,049
Cash and cash equivalents at end of period	149,732	477,885
Supplemental disclosure of non-cash investing and financing information :
Common stock issued for service in relation to Initial public offering	$ 2,718,064